The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| CELLECTIS | SPONS ADS | 15117k103 | 1,205 | 425,726 | SH | DFND | 1 | 0 | 425,726 | 0 | |
| CONSTELLIUM NV | CL A | F21107101 | 216,563 | 16,393,903 | SH | DFND | 1 | 0 | 16,393,903 | 0 | |
| CRITEO S A | SPONS ADS | 226718104 | 66,338 | 2,718,752 | SH | DFND | 1 | 0 | 2,718,752 | 0 | |
| MIRION TECHNOLOGIES INC | COM | 60471A101 | 7,410 | 1,286,446 | SH | DFND | 2 | 0 | 1,286,446 | 0 | |
| REPARE THERAPEUTICS INC | COM | 760273102 | 113 | 8,055 | SH | DFND | 2 | 0 | 8,055 | 0 | |
| SEQUANSCOMMUNICATIONS S A | SPONS ADS | 817323207 | 8,877 | 3,300,018 | SH | DFND | 1 | 0 | 3,300,018 | 0 | |
| STELLANTIS NV | COM | N82405106 | 2,358,303 | 192,703,907 | SH | DFND | 1 | 0 | 192,703,907 | 0 | |
| VECTIVBIO HOLDING AG | COM | H9060V101 | 15,154 | 2,806,217 | SH | DFND | 2 | 0 | 2,806,217 | 0 | |
| VERACYTE INTERNATIONAL | COM | 92337F107 | 3,030 | 152,261 | SH | DFND | 2 | 0 | 152,261 | 0 | |